PHARMANDERLECHT: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
PHARMANDERLECHT
Largest movements
- Tangible fixed assets -€47,544
down €47,544 (-80.3%), from €59,237 to €11,693
of which Furniture and vehicles: -€42,478
- Receivables within one year +€37,197
up €37,197 (+64.4%), from €57,742 to €94,939
of which Trade receivables: +€36,874
- Cash +€33,718
up €33,718 (+84.2%), from €40,038 to €73,756
mainly Investment in fixed assets (net) (+€41,985) and Other debts (+€38,620)
- Stocks and contracts -€8,217
down €8,217 (-6.3%), from €131,317 to €123,100
- Deferred charges and accrued income -€4,970
down €4,970 (-93.6%), from €5,311 to €342
- Other debts +€38,620
new in 2025: €38,620
- Debts after one year -€21,080
no longer reported in 2025 (was €21,080)
- Profit (loss) carried forward -€15,966
down €15,966 (-12.0%), from €132,515 to €116,549
- Trade debts +€11,512
up €11,512 (+13.4%), from €85,816 to €97,328
- Tax, wage and social debts +€10,236
up €10,236 (+37.4%), from €27,336 to €37,572
of which Remuneration and social security: +€10,703
- Gross operating margin -€76,337
down €76,337 (-24.8%), from €308,055 to €231,718
- Taxes -€15,268
no longer reported in 2025 (was €15,268)
- Other operating charges +€11,968
up €11,968 (+119799.2%), from €10 to €11,978
- Depreciation -€10,504
down €10,504 (-65.4%), from €16,063 to €5,559
- Staff costs +€6,089
up €6,089 (+2.7%), from €221,693 to €227,781
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €294,144 | €304,329 | +€10,185 | +3.5% |
| Fixed assets | 21/28 | €59,237 | €11,693 | -€47,544 | -80.3% |
| Tangible fixed assets | 22/27 | €59,237 | €11,693 | -€47,544 | -80.3% |
| Plant, machinery and equipment | 23 | €16,733 | €11,668 | -€5,065 | -30.3% |
| Furniture and vehicles | 24 | €42,504 | €25 | -€42,478 | -99.9% |
| Current assets | 29/58 | €234,907 | €292,636 | +€57,728 | +24.6% |
| Stocks and contracts in progress | 3 | €131,317 | €123,100 | -€8,217 | -6.3% |
| Stocks | 30/36 | €131,317 | €123,100 | -€8,217 | -6.3% |
| Amounts receivable within one year | 40/41 | €57,742 | €94,939 | +€37,197 | +64.4% |
| Trade receivables | 40 | €49,947 | €86,821 | +€36,874 | +73.8% |
| Other amounts receivable | 41 | €7,795 | €8,118 | +€323 | +4.1% |
| Current investments | 50/53 | €500 | €500 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €40,038 | €73,756 | +€33,718 | +84.2% |
| Deferred charges and accrued income | 490/1 | €5,311 | €342 | -€4,970 | -93.6% |
| Total equity and liabilities | 10/49 | €294,144 | €304,329 | +€10,185 | +3.5% |
| Equity | 10/15 | €146,775 | €130,809 | -€15,966 | -10.9% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €1,860 | €1,860 | = | 0.0% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Profit (loss) carried forward | 14 | €132,515 | €116,549 | -€15,966 | -12.0% |
| Amounts payable | 17/49 | €147,369 | €173,519 | +€26,150 | +17.7% |
| Amounts payable after more than one year | 17 | €21,080 | - | -€21,080 | |
| Financial debts | 170/4 | €21,080 | - | -€21,080 | |
| Amounts payable within one year | 42/48 | €126,289 | €173,519 | +€47,230 | +37.4% |
| Current portion of amounts payable after more than one year | 42 | €9,541 | - | -€9,541 | |
| Financial debts | 43 | €3,596 | - | -€3,596 | |
| Credit institutions | 430/8 | €3,596 | - | -€3,596 | |
| Trade debts | 44 | €85,816 | €97,328 | +€11,512 | +13.4% |
| Suppliers | 440/4 | €85,816 | €97,328 | +€11,512 | +13.4% |
| Taxes, remuneration and social security | 45 | €27,336 | €37,572 | +€10,236 | +37.4% |
| Taxes | 450/3 | €467 | - | -€467 | |
| Remuneration and social security | 454/9 | €26,869 | €37,572 | +€10,703 | +39.8% |
| Other amounts payable | 47/48 | - | €38,620 | +€38,620 | |
| Remuneration, social security and pensions | 62 | €221,693 | €227,781 | +€6,089 | +2.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €16,063 | €5,559 | -€10,504 | -65.4% |
| Other operating charges | 640/8 | €10 | €11,978 | +€11,968 | +119799.2% |
| Gross operating margin | 9900 | €308,055 | €231,718 | -€76,337 | -24.8% |
| Operating profit (loss) | 9901 | €70,290 | -€13,600 | -€83,890 | |
| Financial charges | 65/66B | €4,304 | €2,365 | -€1,938 | -45.0% |
| Recurring financial charges | 65 | €4,304 | €2,365 | -€1,938 | -45.0% |
| Profit (loss) for the period before taxes | 9903 | €65,986 | -€15,966 | -€81,952 | |
| Income taxes | 67/77 | €15,268 | - | -€15,268 | |
| Profit (loss) for the period | 9904 | €50,718 | -€15,966 | -€66,684 | |
| Profit (loss) for the period to be appropriated | 9905 | €50,718 | -€15,966 | -€66,684 |
Source: filed annual accounts (NBB), financial years ended 30 September 2024 and 30 September 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 10 October 2026 via checked.be.